Issue 9/2021
Content (13 Articles)
Value of PET imaging for radiation therapy
Constantin Lapa, Ursula Nestle, Nathalie L. Albert, Christian Baues, Ambros Beer, Andreas Buck, Volker Budach, Rebecca Bütof, Stephanie E. Combs, Thorsten Derlin, Matthias Eiber, Wolfgang P. Fendler, Christian Furth, Cihan Gani, Eleni Gkika, Anca-L. Grosu, Christoph Henkenberens, Harun Ilhan, Steffen Löck, Simone Marnitz-Schulze, Matthias Miederer, Michael Mix, Nils H. Nicolay, Maximilian Niyazi, Christoph Pöttgen, Claus M. Rödel, Imke Schatka, Sarah M. Schwarzenboeck, Andrei S. Todica, Wolfgang Weber, Simone Wegen, Thomas Wiegel, Constantinos Zamboglou, Daniel Zips, Klaus Zöphel, Sebastian Zschaeck, Daniela Thorwarth, Esther G. C. Troost, Constantin Lapa, Ursula Nestle, Nathalie L. Albert, Christian Baues, Ambros Beer, Andreas Buck, Volker Budach, Rebecca Bütof, Stephanie E. Combs, Thorsten Derlin, Matthias Eiber, Wolfgang P. Fendler, Christian Furth, Cihan Gani, Eleni Gkika, Anca-L. Grosu, Christoph Henkenberens, Harun Ilhan, Steffen Löck, Simone Marnitz-Schulze, Matthias Miederer, Michael Mix, Nils H. Nicolay, Maximilian Niyazi, Christoph Pöttgen, Claus M. Rödel, Imke Schatka, Sarah M. Schwarzenboeck, Andrei S. Todica, Wolfgang Weber, Simone Wegen, Thomas Wiegel, Constantinos Zamboglou, Daniel Zips, Klaus Zöphel, Sebastian Zschaeck, Daniela Thorwarth, Esther G. C. Troost
[F18] FDG-PET/CT for manual or semiautomated GTV delineation of the primary tumor for radiation therapy planning in patients with esophageal cancer: is it useful?
Franziska Walter, Constanze Jell, Barbara Zollner, Claudia Andrae, Sabine Gerum, Harun Ilhan, Claus Belka, Maximilian Niyazi, Falk Roeder
Motion-compensated FDG PET/CT for oesophageal cancer
Francine E. M. Voncken, Erik Vegt, Johanna W. van Sandick, Jolanda M. van Dieren, Cecile Grootscholten, Annemarieke Bartels-Rutten, Steven L. Takken, Jan-Jakob Sonke, Jeroen B. van de Kamer, Berthe M. P. Aleman
Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial
David Krug, Reinhard Vonthein, Andreas Schreiber, Alexander D. Boicev, Jörg Zimmer, Reinhold Laubach, Nicola Weidner, Stefan Dinges, Matthias Hipp, Ralf Schneider, Evelyn Weinstrauch, Thomas Martin, Juliane Hörner-Rieber, Denise Olbrich, Alicia Illen, Nicole Heßler, Inke R. König, Kathrin Dellas, Jürgen Dunst
Intraoperative radiotherapy boost as part of breast-conservation therapy for breast cancer: a single-institution retrospective analysis
Raluca Stoian, Thalia Erbes, Constantinos Zamboglou, Jutta Scholber, Mark Gainey, Ilias Sachpazidis, Erik Haehl, Simon K. B. Spohn, Vivek Verma, David Krug, Alexander Rühle, Ingolf Juhasz-Böss, Anca-Ligia Grosu, Nils H. Nicolay, Tanja Sprave
Incidental axillary dose delivery to axillary lymph node levels I–III by different techniques of whole-breast irradiation: a systematic literature review
Martin Schmitt, Yvan Pin, Carole Pflumio, Carole Mathelin, Xavier Pivot, Georges Noel
MicroRNA-29b regulates the radiosensitivity of esophageal squamous cell carcinoma by regulating the BTG2-mediated cell cycle
Dongli Guo, Jing Jin, Jianghui Liu, Xiaoping Dong, Daojuan Li, Yutong He
Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose
L. Wilke, C. Moustakis, O. Blanck, D. Albers, C. Albrecht, Y. Avcu, R. Boucenna, K. Buchauer, T. Etzelstorfer, C. Henkenberens, D. Jeller, K. Jurianz, C. Kornhuber, M. Kretschmer, S. Lotze, K. Meier, P. Pemler, A. Riegler, A. Röser, D. Schmidhalter, K. H. Spruijt, G. Surber, V. Vallet, R. Wiehle, J. Willner, P. Winkler, A. Wittig, M. Guckenberger, S. Tanadini-Lang
Inoperable CASTLE of the thyroid gland treated with radical radiotherapy with complete remission
Petra Kovářová, Radovan Vojtíšek, Michal Krčma, Ondřej Daum, Jan Baxa, Emília Sukovská, Jindřich Fínek
Moderate Hypofraktionierung beim Harnblasenkarzinom – ein neuer Versorgungsstandard?
Oliver J. Ott
Konditionierung mit Ganzkörperbestrahlung oder Chemotherapie bei ALL im Kindesalter
Martin G. Sauer
Strahlentherapie mit 24-Gy-Einzeldosis und 3-Fraktionen-SBRT zur Behandlung von oligometastasierten Malignomen?
Hossein Hemmatazad, Etienne Mathier, Daniel M. Aebersold, Mohamed Shelan
Prädiktion der pathologischen Komplettremission beim Ösophaguskarzinom nach neoadjuvanter Radiochemotherapie mittels FDG-PET/CT und diffusionsgewichteter MRT
Markus Hecht, Sabine Semrau